Management
Immunetrics is staffed by a team of carefully trained Ph.D.-level biologists and mathematical modelers under the leadership of:
Steven Chang, M.S., CEO, board member, is a successful technology entrepreneur with more than 18 years of experience in developing complex computer models, optimization algorithms, and data mining systems. He was the founding Chairman of the board of directors for SCAI (Society for Complexity in Acute Illnesses). As founding CEO of Futuristics Labs, Steve raised two rounds of financing totaling over $10 million. Futuristics' proprietary technologies enabled real-time ad hoc query processing on terabyte sized databases with no loss in data resolution. Prior to founding Futuristics, Steve headed up the Intelligent Software Systems group at Westinghouse/CBS Corporation's Science and Technology Center and developed decision optimization and computer modeling systems that were successfully deployed in many Fortune 500 companies, including Kraft Foods, Colgate-Palmolive, Nestle, and Airborne Express. He was also instrumental in establishing the first Westinghouse presence on the Internet and was the recipient of two George Westinghouse Signature Awards for Excellence. Steve attained both BS and MS degrees in Electrical Engineering from the Rensselaer Polytechnic Institute.
John Bartels, Director of Advanced Research, has been developing mathematical models for 10 years, primarily in biological applications. John provides the technical direction and foundation for Immunetrics' custom simulation platforms and proprietary tools. Prior to joining Immunetrics, John held senior engineering positions at Nomos Corporation, Westinghouse Electric Corporation, and Digital Equipment Corporation. John holds a BS in Computer Science from the Rensselaer Polytechnic Institute and an MS in Mathematics from the University of Pittsburgh.
Patricia Rogan, Vice President, Operations, has more than twenty years of experience in executive financial and administrative management at public, private and startup technology companies, including software and biotechnology firms. Prior to joining Immunetrics, Pat was an executive at Innovation Works, Inc., a regional seed stage investor in technology companies. She previously held executive management positions at LaunchCyte, LLC and Dravo Corporation. Pat holds a B.A. and an MBA from the University of Pittsburgh.